Literature DB >> 31119638

Experimental Human Infection with Neisseria gonorrhoeae.

Marcia M Hobbs1, Joseph A Duncan2.   

Abstract

Experimental infection of male volunteers with Neisseria gonorrhoeae is safe and reproduces the clinical features of naturally acquired gonococcal urethritis. The human model is useful for testing the importance of putative gonococcal virulence factors for urethral infection in men and the model presents opportunities to examine host immune responses that may be exploited or improved in development and testing of gonococcal vaccines. In this chapter, we describe methods for production, characterization, and storage of N. gonorrhoeae stocks for experimental human challenge, preparation and delivery of inoculum suspensions, monitoring experimental infection, and statistical considerations for data analysis.

Entities:  

Keywords:  Experimental human infection; Gonococcal urethritis; Neisseria gonorrhoeae

Mesh:

Substances:

Year:  2019        PMID: 31119638      PMCID: PMC7299166          DOI: 10.1007/978-1-4939-9496-0_25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

Review 1.  Use of mixed infections with Salmonella strains to study virulence genes and their interactions in vivo.

Authors:  C R Beuzón; D W Holden
Journal:  Microbes Infect       Date:  2001 Nov-Dec       Impact factor: 2.700

2.  Antigenic and structural differences among six proteins II expressed by a single strain of Neisseria gonorrhoeae.

Authors:  D S Barritt; R S Schwalbe; D G Klapper; J G Cannon
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

3.  Establishment of a human CEACAM1 transgenic mouse model for the study of gonococcal infections.

Authors:  Guocai Li; Hongmei Jiao; Hua Yan; Jinsong Wang; Xiaohong Wang; Mingchun Ji
Journal:  J Microbiol Methods       Date:  2011-10-01       Impact factor: 2.363

4.  Construction of mutant strains of Neisseria gonorrhoeae lacking new antibiotic resistance markers using a two gene cassette with positive and negative selection.

Authors:  D M Johnston; J G Cannon
Journal:  Gene       Date:  1999-08-05       Impact factor: 3.688

5.  Transgenic mice expressing human transferrin as a model for meningococcal infection.

Authors:  Maria-Leticia Zarantonelli; Marek Szatanik; Dario Giorgini; Eva Hong; Michel Huerre; Florian Guillou; Jean-Michel Alonso; Muhamed-Kheir Taha
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

6.  Multiple gonococcal pilin antigenic variants are produced during experimental human infections.

Authors:  H S Seifert; C J Wright; A E Jerse; M S Cohen; J G Cannon
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

7.  Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men.

Authors:  H Schneider; J M Griffiss; J W Boslego; P J Hitchcock; K M Zahos; M A Apicella
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

Review 8.  Vaccine research for gonococcal infections: where are we?

Authors:  Ann E Jerse; Carolyn D Deal
Journal:  Sex Transm Infect       Date:  2013-12       Impact factor: 3.519

9.  Estradiol-Treated Female Mice as Surrogate Hosts for Neisseria gonorrhoeae Genital Tract Infections.

Authors:  Ann E Jerse; Hong Wu; Mathanraj Packiam; Rachel A Vonck; Afrin A Begum; Lotisha E Garvin
Journal:  Front Microbiol       Date:  2011-07-01       Impact factor: 5.640

10.  Experimental Gonococcal Infection in Male Volunteers: Cumulative Experience with Neisseria gonorrhoeae Strains FA1090 and MS11mkC.

Authors:  Marcia M Hobbs; P Frederick Sparling; Myron S Cohen; William M Shafer; Carolyn D Deal; Ann E Jerse
Journal:  Front Microbiol       Date:  2011-05-31       Impact factor: 5.640

View more
  1 in total

1.  The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.

Authors:  Isabelle Leduc; Kristie L Connolly; Afrin Begum; Knashka Underwood; Stephen Darnell; William M Shafer; Jacqueline T Balthazar; Andrew N Macintyre; Gregory D Sempowski; Joseph A Duncan; Marguerite B Little; Nazia Rahman; Eric C Garges; Ann E Jerse
Journal:  PLoS Pathog       Date:  2020-12-08       Impact factor: 6.823

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.